Target intelligence / Profile preview

Cell-surface N-linked galactose residues (N-linked Gal)

Target
N-linked Gal
Molecular classification
Carbohydrate, Glycan, Post-translational modification
01

Overview

Cell-surface N-linked galactose residues are specific carbohydrate structures attached to the nitrogen atom of asparagine residues on proteins through N-glycosylation (Varki et al., 2017). These residues typically appear at the terminal or sub-terminal positions of complex oligosaccharide chains and are often masked by sialic acid in healthy physiological states. When terminal sialic acid is removed—a process often associated with cellular aging or pathological conditions—the exposed galactose residues serve as a critical biological signal for the clearance of glycoproteins from circulation via the asialoglycoprotein receptor (ASGPR) located on hepatocytes (Stockert, 1995). In oncology, aberrant glycosylation patterns frequently result in the over-exposure of these galactose residues, which can influence tumor metastasis, cell adhesion, and immune system evasion (Pinho & Reis, 2015). From a therapeutic perspective, these residues are highly significant as they are the primary target for galactose- and N-acetylgalactosamine (GalNAc)-conjugated delivery systems, which exploit the high-capacity endocytic pathway of the liver to deliver RNA interference (RNAi) therapies and other oligonucleotides (D'Souza & Devarajan, 2015). Additionally, experimental strategies involve using neuraminidase enzymes to intentionally expose these residues on tumor cells to enhance their recognition and destruction by the immune system.

Other names
Terminal galactose residuesN-glycan galactoseGalactose-terminated glycansAsialo-glycansExposed galactose epitopes
02

Mechanism of action

Binding to the asialoglycoprotein receptor (ASGPR) to facilitate receptor-mediated endocytosis and hepatic drug delivery, or serving as a recognition site for carbohydrate-binding proteins (lectins) to trigger cellular responses.

03

Biological functions

Cell-cell recognitionGlycoprotein clearanceProtein stabilityCell signalingImmune modulation
04

Disease associations

CancerInfectionLiver diseaseInflammation
05

Safety considerations

Hepatotoxicity due to concentrated liver uptakeRapid systemic clearance by the reticuloendothelial systemPotential off-target binding to non-target lectinsImmunogenicity of glycan-modified therapeutics
06

Interacting drugs

Inclisiran

5 more in the full profile.

07

Biomarkers

Serum asialoglycoprotein levelsLectin-binding glycan profilesASGPR expression levels

Beyond the preview

Go deeper on Cell-surface N-linked galactose residues (N-linked Gal).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell-surface N-linked galactose residues (N-linked Gal).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call